BAT Expands Sales Channels for "Glo Hyper Pro" in Korea

BAT by 2FIRSTS.ai
Jul.29.2024
BAT Expands Sales Channels for "Glo Hyper Pro" in Korea
British American Tobacco's Korean subsidiary expands sales of HNB device "Glo Hyper Pro" to national convenience stores with discounts.

According to N.News on July 29th, British American Tobacco Korea subsidiary announced that it will further expand the sales channels of its HNB device "Glo Hyper Pro" to major convenience stores such as CU, GS25, and Seven-eleven across the country.

 

To commemorate their debut in convenience stores, a discount of up to 30,000 Korean won (approximately 21.73 US dollars) will be offered from now until the 25th of next month, lasting for about a month.

 

The promotion will take place simultaneously on online and offline platforms such as convenience stores, official websites, Naver, and Kakao nationwide. The Glo Hyper Pro device, originally priced at 69,000 Korean won ($49.98), will be sold at a discounted price of 39,000 Korean won ($28.25).

 

A representative of the company stated,

 

After several upgrades, Glo Hyper Pro has received an average positive feedback rating of 4.86 out of 5 on major e-commerce platforms just two months after its launch. Through this convenience store entry and promotional activities, it is hoped that more adult smokers will have the opportunity to experience Hyper Pro.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Global Tobacco Companies’ Latest Earnings Review: Nicotine Pouch Business Shows Broad Strength, Emerging as a Key Growth Driver
Global Tobacco Companies’ Latest Earnings Review: Nicotine Pouch Business Shows Broad Strength, Emerging as a Key Growth Driver
Multiple global tobacco and next-generation nicotine companies reported solid Q3 performance, with the nicotine-pouch category showing broad-based strength across seven firms. Growth was reflected in higher shipment volumes, expanded market coverage, and new product launches. Several companies also reported rising revenue contributions from pouches and continued investment in this fast-growing segment, underscoring its position as a key driver of future growth.
Nov.14
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai
Kentucky to Require Tobacco and Vape Retailers to Be Licensed Starting January 2026
Kentucky to Require Tobacco and Vape Retailers to Be Licensed Starting January 2026
The Kentucky Public Protection Cabinet has reminded all businesses selling tobacco, nicotine, and vapor products that they must be licensed by the Kentucky Department of Alcoholic Beverage Control (ABC) by January 1, 2026. The requirement stems from Senate Bill 100, signed into law by Governor Andy Beshear on March 24, 2025, aimed at strengthening youth protection and enforcing compliance against unlicensed sales.
Nov.17 by 2FIRSTS.ai
 Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.
News
Dec.20
Thailand National Health Commission Advances Vape Regulation Aligned with Anti-Drug Agenda
Thailand National Health Commission Advances Vape Regulation Aligned with Anti-Drug Agenda
Thailand’s Deputy Prime Minister Sophon Saram, who chairs the National Health Commission (NHC), presided over a meeting aligning the nation’s e-cigarette control policies with the government’s “Quick Big Win” anti-drug strategy. The session reviewed progress under the National Health Assembly Resolution on Protecting Children and Youth from E-Cigarettes, which includes five key measures on awareness, enforcement, and prevention.
Nov.05 by 2FIRSTS.ai
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.
Oct.28 by 2FIRSTS.ai